NDC 72730-202

TRUSELTIQ

Infigratinib

TRUSELTIQ is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Qed Therapeutics, Inc.. The primary component is Infigratinib.

• Product ID: 72730-202_0529ba94-9541-4ce3-8b59-0afb1e44e0f1
• NDC: 72730-202
• Product Type: Human Prescription Drug
• Proprietary Name: TRUSELTIQ
• Generic Name: Infigratinib
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2021-05-28
• Marketing Category: NDA /
• Application Number: NDA214622
• Labeler Name: QED Therapeutics, Inc.
• Substance Name: INFIGRATINIB
• Active Ingredient Strength: 75 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 72730-202-01

1 BLISTER PACK in 1 CARTON (72730-202-01) > 63 CAPSULE in 1 BLISTER PACK

• Marketing Start Date: 2021-05-28
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "TRUSELTIQ" or generic name "Infigratinib"

NDC	Brand Name	Generic Name
72730-101	TRUSELTIQ	infigratinib
72730-111	TRUSELTIQ	infigratinib
72730-202	TRUSELTIQ	infigratinib
72730-506	TRUSELTIQ	infigratinib